• Phase 3 Trials Test Upadacitinib for Moderately to Severely Active UC or CD
  • Oral Treatment Candidate Etrasimod Found to be Safe and Effective for Ulcerative Colitis, Open-label Trial Extension Shows
  • Women with Crohn’s Disease Have Higher Risk of Mental Illness Post-pregnancy, Study Suggests
  • Nominations Open for Sherman Prizes for Professional Achievement in IBD
  • Malnutrition Puts Children with Crohn’s at Higher Risk of Post-surgery Complications, Study Says
  • Mind/Body Wellness as Way of Treating IBD: A Nutritionist’s View
  • IBD May Raise Person’s Risk of Prostate Cancer, Study Reports
  • Diet and Lifestyle Changes to Help Those with IBD ‘Take Back Control of Your Health’: A Nutritionist’s View
  • Abivax to Present Results of Trials of ABX464 as Ulcerative Colitis Therapy
  • Immunic Will Develop IMU-856, Promising IBD Therapy
  • Protagonist Therapeutics Starts Phase 1 Trial of Potential Ulcerative Colitis Treatment PN-10943
  • Janssen Launching Phase 1 Trial Testing VE202 for Potential IBD Treatment